蓝帆医疗：接受华西证券等投资者调研

Group 1 - Bluefan Medical announced that on September 18, 2025, it will accept investor research from Huaxi Securities and others, with participation from the company's director and president, Zhong Shu Qiao, who will address investor inquiries [1] - The company is actively engaging with investors to provide insights and updates on its operations and future prospects [1] Group 2 - The article highlights the ongoing discussions regarding interest rate adjustments by the Federal Reserve, indicating a delicate balance in monetary policy [1] - The mention of differing opinions within the Federal Reserve, including a dissenting vote, reflects the complexities of economic decision-making that could impact market conditions [1]